BDDG- The Journey to an Investigational New Drug (IND)

BDDG- The Journey to an Investigational New Drug (IND)
Please join us for an informative discussion with our guest speaker Ed Lobenhofer via Zoom.

Bioactive Discovery and Development Group Seminar


Please join us for an informative evening of discussion with our guest speaker Ed Lobenhofer on Thursday February 25th at 10am via Zoom. 

Ed Lobenhofer is a Director in the Translational Safety and Bioanalytical Sciences Department at Amgen.  He leads a team of scientists developing and implementing the nonclinical safety strategy needed to support the development of drug candidates across different modalities and disease indications. Prior to joining Amgen, Ed began his scientific career concentrated on the application of genomic technologies to identifying biomarkers of disease as well as the field of toxicology. Ed received his undergraduate degree in Biology Education from Millikin University and his PhD in Cell and Molecular Biology from the Pathology Department at Duke University.

RACI member                                   Free

Non-Member                                     $5 

Student Non-Member                     Free or $5 (The first five Student Non-Members to register will be able to attend for free)

We thank our generous sponsors for supporting this event

Please sign in or create an account to register for this event. Registrations will close on 24/02/21 at 4pm.

When
2/25/2021 10:00 AM - 11:00 AM
Where
Online AUSTRALIA

If you haven't done so already you have to sign into the site before you can register for an event.

 

Event Registration

 

If you haven't done so already you have to sign into the site before you can register for an event.

If you are an RACI member or have been to an event in the past you are already in the system and just have to input your username [normally your email address] and your password.

 If this is your first time you need to click on the "create account" tab and follow the prompts.

 

 

Sign In

You may also be interested in